Hua Medicine Ltd. announced that it has received $25 million in its series B round of funding led by new investor Ally Bridge Group on January 8, 2015. The transaction includes participation from other new investors, Frontline BioVentures, TF Capital, and existing investors, Arch Venture Partners, L.P., Venrock, Fidelity Biosciences, WuXi Healthcare Ventures, and SAIL Capital Partners LLC.

On January 8, 2015, Hua Medicine Ltd. closed the transaction.